Rho-kinase and GTP-ase Rho are important regulators of vascular tone and blood pressure. The aim of this study was to investigate the role of Rho-kinase in artery reactions induced by angiotensin II (ANG II) and the effects of ischemia-reperfusion injury as well as the function of intra-and extracellular calcium in these reactions. Experiments were performed on mesenteric superior arteries procured from cadaveric organ donors and conserved under the same conditions as transplanted kidneys. The vascular contraction in reaction to ANG II was measured in the presence of Rho-kinase inhibitor Y-27632, after ischemia and reperfusion, in Ca 2+ and Ca 2+ -free solution. The maximal response to ANG II was reduced after ischemia, while an increase was observed after reperfusion. Vascular contraction induced by ANG II was decreased by Y-27632. Y-27632 reduced vascular contraction after reperfusion, both in Ca 2+ and Ca 2+ -free solution. Reperfusion augments vascular contraction in reaction to ANG II. The Rho-kinase inhibitor Y-27632 reduces the hypersensitivity to ANG II after reperfusion mediated by both intra-and extracellular calcium. These results confirm the role of Rho-kinase in receptor-independent function of ANG II and in reperfusion-induced hypersensitivity.
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IntroductIon
Ischemia-reperfusion injury is a major factor influencing early and late results of kidney transplantation. Many efforts to reduce this problem have been made in kidney procurement and transplantation and one of the possible ways to improve graft function is to limit the post-reperfusion no-reflow phenomenon. Rho-kinase inhibitors are among substances that can suppress this damaging effect -they should limit the influence of angiotensin II (ANG II) on reperfused arteries.
The most important and best known function of ANG II depends on activation of AT 1 receptors [1, 6, 20, 36] .
In the circulatory system these receptors are present in smooth muscle cells and take part in vessel contraction, proliferation and inflammatory processes induced by ANG II [8, 12] . AT 1 receptors are metabotropic G q -protein coupled receptors. G-protein activates phospholipase C (PLC) and synthesis of inositol trisphosphate (IP 3 ) and diacylglycerol (DAG) -second messengers in ANG II dependent processes. After binding to IP 3 receptors in endoplasmic reticulum, IP 3 induces release of Ca 2+ and vascular smooth muscle contraction while DAG activates protein kinase C.
The latest research suggests that Rho-kinase and GTP-ase Rho, which activates it, play a key role in regulation of vascular tone and blood pressure in vivo [9, 27, 34] . Numerous in vivo studies have shown that the active form of Rho-kinase mediates myosin light chain phosphorylation, activating binding of Ca 2+ by contractile proteins and thus inducing vessel smooth muscle contraction [2, 5] . Wang et al. (2001) reported that hypoxia causes a considerable, duration-dependent, increase in Rho-kinase activity and myosin light chain phosphorylation [37] . In this research, we assessed the influence of the Rho-kinase inhibitor Y-72632 on angiotensin II induced smooth muscle reaction, including the role of intra-and extracellular Ca 2+ and effects of ischemia/reperfusion injury. Although the role of Rho-kinase and its inhibitors in ischemia/reperfusion injury have been investigated in animals in several studies, the model used in this experiment -reperfusion of human mesenteric arteries, harvested during kidney procurement from deceased donors -should more accurately reflect processes occurring in transplanted kidney vessels after reperfusion.
MaterIal and Methods:
The experiment was approved by the review board of Nicolaus Copernicus University. Superior mesenteric arteries were procured from deceased kidney donors. They were stored in UW storage solution at a temperature of 4°C for an average time of 14.8±3.6 h, the same as transplanted kidneys. After being dissected and cleared from surrounding tissue, a 15 mm long segment was cannulated and connected to the perfusion apparatus. Perfusion pressure was measured continuously using a pressure transducer (Gould Statham, type P-23ID) and universal coupler (Narco 7189) of a Narco Narcotrace 40 physiograph (Narco Bio-Systems). Perfusion flow was maintained by a peristaltic pump type 315, Zalimp (Poland). The sample was then placed in a 20 mL container filled with oxygenated normal saline at 37°C. Perfusion solution flow was gradually increased using a peristaltic pump until 1 mL/min was reached.
To estimate the influence of hypoxia on artery reaction, perfusion and oxygen supply was stopped for a set period of time (30 or 60 min), then perfusion was resumed and artery reaction was measured. After a set time of perfusion with oxygenated solution, artery reaction was measured for the second time. Drugs used in the experiment were purchased from Sigma-Aldrich, Poland.
Concentration-response curves (CRCs) for ANG II before and after addition of Rho-kinase inhibitor (1, 3 and 10 μM) and after ischemia/reperfusion were analyzed according to modified receptor theory [13, 14] . EC 50 (half maximal effective concentration) and E max (maximal response) values were used to estimate changes in artery responses to ANG II.
Two models were used to estimate the role of extra-and intracellular Ca 2+ :
• 
dIscussIon
The aim of this research was to investigate the role of Rho-kinase in ischemia/reperfusion induced artery hypersensitivity to ANG II by estimating the influence of Rho-kinase inhibitor on the smooth muscle reaction induced by ANG II and effects of ischemia/reperfusion injury, including the role of intra-and extracellular Ca 2+ . The arteries used in the experiment were harvested together with organs and stored in the same conditions, thus being a model of transplanted organ arteries' reaction to ischemia/reperfusion injury. In our previous research, we have studied other aspects of ischemia/reperfusion injury [30, 31] and successfully used this model [28] . Previous research suggests that ANG II increases cytosolic Ca 2+ level by IP 3 -dependent release from endoplasmic reticulum and activation of IP 3 -independent membrane Ca 2+ ion channels and influx of extracellular Ca 2+ [32] . G-protein coupled receptor induced vascular smooth muscle contraction depends on the level of myosin light chain (MLC) phosphorylation, which is determined by the balance between activity of myosin light chain kinase (MLCK) and myosin light chain phosphatase (MLCP) [22, 29] . MLCK is activated by the Ca 2+ -calmodulin complex. ANG II, by initiating the increase of intracellular Ca 2+ concentration, activates MLCK, which phosphorylates myosin light chains and induces smooth muscle contraction. Inhibition of MLCP, by preventing dephosphorylation of MLC, increases the level of MLC phosphorylation for a given intracellular Ca 2+ concentration and increases myofilament sensitivity to Ca 2+ . The RhoA-Rho-kinase signal system is the main regulator of MLCP activity. Activated Rho-kinase inhibits MLCP and thus maintains MLC phosphorylation and contraction of smooth muscle, even at lower cytosolic Ca 2+ levels. RhoA-Rho-kinase signal system agonists may also mediate Ca 2+ flow into the cytoplasm [2, 7, 10, 18, 39] . Inhibition of Rho-kinase causes, as reported by Ishizaki et al. (2000) , an increase in MLCP activity, dephosphorylation of MLC and relaxation of smooth muscle. Y-27632 may also cause relaxation by inhibiting agonist-induced Ca 2+ transport and reduction of MLCK activity [11, 16, 19, 23, 24, 37] . Research analyzing the influence of hypoxia and reperfu- Fig. 2, Fig. 3 ], the hypersensitivity, expressed as the time-dependent increase of perfusion pressure and maximal reaction, is still present (although not significant for reperfusion shorter than 60 min) but significantly reduced. In a Ca 2+ -free environment, where influx of extracellular Ca 2+ through membrane Ca 2+ ion channels could not occur, the hypersensitivity to ANG II was less expressed -the perfusion pressure was lower [ Fig. 4, Fig. 5 ], and it was also correlated with hypoxia time -higher perfusion pressure values were observed after longer hypoxia, which confirms the role of Ca 2+ in this phenomenon. Inhibition of Rho-kinase significantly reduced hypersensitivity to ANG II caused by ischemia/ reperfusion not only in Ca 2+ -containing but also in Ca 2+--free solution. Inhibition of Rho-kinase and increase of MLCP activity induce relaxation of vessel smooth muscle, previously contracted in reaction to ANG II, and reduce hypersensitivity to ANG II caused by ischemia/reperfusion. Previous research has proven that Y-27632 has a similar effect on arteries isolated from human placenta [33] . ANG II activates the RhoA/Rho-kinase signaling system, activates MLCP and strengthens smooth muscle contraction. Agonists activating the RhoA/Rho-kinase signaling system may also mediate Ca 2+ flow from the extracellular space into the cytoplasm. The presented results confirm participation of both PLC and IP 3 dependent and independent components in ischemia/reperfusion induced hypersensitivity to ANG II. The second component is also effectively inhibited by Y-27632, as was proven in the experiment with human mesenteric arteries. These experiments confirmed the role of Rho-kinase activation in reaction to ANG II and ischemia/reperfusion induced hypersensitivity. Similar results were obtained for human chorionic arteries [34] . The chain of reactions initiated by RhoA/Rho-kinase plays an important role in circulatory system pathophysiological processes, such as hypertension and arteriosclerosis [11, 15, 19, 25, 26, 35] . It was proven that RhoA/Rho-kinase occupies a prominent place in the C-reactive protein signaling system, which is involved in arteriosclerosis and thrombosis, and that it is a factor sensitizing smooth muscle to Ca 2+ as well as connected with the inflammatory cascade and initiating arteriosclerosis and vessel remodeling [3, 4, 17] . Inhibition of Rho-kinase causes dephosphorylation of MLC and thus reduces smooth muscle sensitivity to Ca 2+ , which may be important in case of ischemia/reperfusion related Ca 2+ overload. Therefore, Rho-kinase is a potentially attractive therapeutic target and inhibiting its activity may reduce the effect of ischemia/reperfusion injury in transplanted organs. 
